Immunology News and Research

Latest Immunology News and Research

Loyola presents Scientist of the Year awards

Susan Baker, PhD, a leading researcher of a class of viruses that includes Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), has been named Senior Scientist of the Year at Loyola University Chicago Stritch School of Medicine. Wei Qiu, PhD, who is researching the molecular mechanisms of liver cancer, has been named Junior Scientist of the Year.

6 Nov 2015

Majority of people not allergic to intravenous penicillins, say ACAAI allergists

Most people who think they're allergic to penicillin have been told so by a doctor after they've had a reaction to the drug. And the majority, even though they've never been allergy tested, never take penicillin again.

6 Nov 2015

Researchers discover potential solution for side effects of immunotherapy treatment for Alzheimer's

It is estimated that 46.8 million people worldwide are living with dementia, with Alzheimer's disease the most common form.

5 Nov 2015

New research shows siblings of children with food allergies have sensitivity, but not true allergy

If one child in a family has a food allergy, the reasoning sometimes goes, chances are good that siblings might also have food allergies. Not necessarily, according to new research which shows that 53 percent of siblings of children with food allergies had a food sensitivity, but only 13 percent had actual food allergy.

5 Nov 2015

New book by Virginia Tech researchers explains a set of techniques to model the immune system

The complexity of the human immune response has been difficult to characterize on a 'big picture' level, but researchers at the Virginia Bioinformatics Institute at Virginia Tech have written the book on how it can be done.

5 Nov 2015

New therapy attacks the source of asthma, treats the disease at cellular level

Imagine you suffer from severe asthma, and you've tried every treatment available, but nothing has worked. You still can't breathe. Then a new therapy comes along that attacks the source of the asthma, as opposed to the symptoms, and treats the disease at a cellular level. That's the promise of biologics, and the topic of four presentations at the 2015 ACAAI Annual Scientific Meeting in San Antonio, November 5-9.

5 Nov 2015

Breastfeeding may not protect against allergies

Pregnant women and new mothers receive many messages regarding the benefits of exclusive breastfeeding for babies in the first year of life. Breastfeeding is thought to reduce the risk of allergic rhinitis (hay fever), asthma, food allergies and eczema in children.

5 Nov 2015

Many seasonal allergy sufferers take OTC products rather prescription medications

Anyone suffering with seasonal allergies knows the local pharmacy carries shelves full of over-the-counter medications to help manage symptoms. Unfortunately, most seasonal allergy sufferers take over-the counter (OTC) products rather than the treatments they actually prefer - prescription medications.

5 Nov 2015

New vaccine candidate shows great promise at fighting respiratory syncytial virus

Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.

5 Nov 2015

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

When it comes to fending off disease and helping prevent people from falling ill, the body's immune system -- armed with T-cells that help eliminate cancer cells, virus-infected cells and more -- is second to none. But exactly how the immune system works remains, in many ways, a mystery, as there are numerous cell types whose functions and interactions with our immune systems have not been well understood.

5 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

International research project examines effectiveness of tried and tested medicines for different diseases

The Medical University of Vienna is coordinating an international research project, which investigates the effectiveness of tried and tested medicines for the treatment of some of the heaviest burdens of our modern society including diseases such as cancer, diabetes and cardiovascular diseases. One molecule that these disorders have in common is a receptor known as the calcium-sensing receptor (CaSR), which is the molecular starting point of this project.

4 Nov 2015

Approval to start trial of Videregen's replacement trachea technology

The INSPIRE consortium, led by Videregen Ltd, has received approval from the MHRA1 to start a UK clinical trial with its tissue engineered replacement trachea.

3 Nov 2015

Findings suggest potential metabolic pathway against cancer

When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer.

3 Nov 2015

Rheumatoid arthritis significantly increases risk of death due to cardiovascular causes

Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.

3 Nov 2015

Small subtype of immune cells appears to prevent obesity

We tend to think of the immune system as guarding us against bacteria, viruses and assorted foreign invaders, but this system has some other surprising roles. Weizmann Institute researchers have now identified a small subtype of immune cells that appears to prevent metabolic syndrome: obesity, high blood pressure, and high levels of blood sugar and cholesterol.

3 Nov 2015

New research may offer strategies for developing toxoplasma-inactivated vaccine

Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer.

31 Oct 2015

New anti-malarial ‘biobricks' could pave way for easier, cost-effective production of artemisinin drug

Students from Trinity College Dublin have successfully created anti-malarial ‘biobricks', which could pave the way for easier and more cost-effective production of the key drug artemisinin.

31 Oct 2015

Basic research for developing toxoplasma vaccine underway

Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer. Pregnant women who are infected may suffer a miscarriage or the newborn child may suffer from a congenital disease. Currently, a toxoplasma vaccine for humans is not available. Using experimental animals such as mice, basic research for developing an inactivated vaccine is underway.

30 Oct 2015

Scientists one step closer to developing new treatment for inflammatory bowel disease

For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.

30 Oct 2015

Immunology News and Research

Latest Immunology News and Research

Loyola presents Scientist of the Year awards

Majority of people not allergic to intravenous penicillins, say ACAAI allergists

Researchers discover potential solution for side effects of immunotherapy treatment for Alzheimer's

New research shows siblings of children with food allergies have sensitivity, but not true allergy

New book by Virginia Tech researchers explains a set of techniques to model the immune system

New therapy attacks the source of asthma, treats the disease at cellular level

Breastfeeding may not protect against allergies

Many seasonal allergy sufferers take OTC products rather prescription medications

New vaccine candidate shows great promise at fighting respiratory syncytial virus

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

International research project examines effectiveness of tried and tested medicines for different diseases

Approval to start trial of Videregen's replacement trachea technology

Findings suggest potential metabolic pathway against cancer

Rheumatoid arthritis significantly increases risk of death due to cardiovascular causes

Small subtype of immune cells appears to prevent obesity

New research may offer strategies for developing toxoplasma-inactivated vaccine

New anti-malarial ‘biobricks' could pave way for easier, cost-effective production of artemisinin drug

Basic research for developing toxoplasma vaccine underway

Scientists one step closer to developing new treatment for inflammatory bowel disease

Industry focus eBook - Immunology (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production